Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies


Our achievements would not be possible without the outstanding team that make up Shield Therapeutics’ staff, management and board of directors.

Non-Executive Chairman

Hans Peter Hasler

Hans Peter joined the Board of Shield Therapeutics plc in July 2018. His prior experience includes roles as COO at Elan Corporation, and several senior positions at Biogen, Inc., including Chief Operations Officer. Previously, Hans Peter was at Wyeth Pharmaceuticals as Senior Vice President, Chief Marketing Officer and Managing Director of Wyeth Group Germany, Wyeth-Lederle Switzerland, Austria and CEE.

Member of the Audit Committee and Nomination Committee.

Back to team